Chest MRI to diagnose early diaphragmatic weakness in Pompe disease

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Chest MRI to diagnose early diaphragmatic weakness in Pompe disease. / Harlaar, Laurike; Ciet, Pierluigi; van Tulder, Gijs; Pittaro, Alice; van Kooten, Harmke A.; van der Beek, Nadine A.M.E.; Brusse, Esther; Wielopolski, Piotr A.; de Bruijne, Marleen; van der Ploeg, Ans T.; Tiddens, Harm A.W.M.; van Doorn, Pieter A.

In: Orphanet Journal of Rare Diseases, Vol. 16, No. 1, 21, 2021, p. 1-12.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Harlaar, L, Ciet, P, van Tulder, G, Pittaro, A, van Kooten, HA, van der Beek, NAME, Brusse, E, Wielopolski, PA, de Bruijne, M, van der Ploeg, AT, Tiddens, HAWM & van Doorn, PA 2021, 'Chest MRI to diagnose early diaphragmatic weakness in Pompe disease', Orphanet Journal of Rare Diseases, vol. 16, no. 1, 21, pp. 1-12. https://doi.org/10.1186/s13023-020-01627-x

APA

Harlaar, L., Ciet, P., van Tulder, G., Pittaro, A., van Kooten, H. A., van der Beek, N. A. M. E., Brusse, E., Wielopolski, P. A., de Bruijne, M., van der Ploeg, A. T., Tiddens, H. A. W. M., & van Doorn, P. A. (2021). Chest MRI to diagnose early diaphragmatic weakness in Pompe disease. Orphanet Journal of Rare Diseases, 16(1), 1-12. [21]. https://doi.org/10.1186/s13023-020-01627-x

Vancouver

Harlaar L, Ciet P, van Tulder G, Pittaro A, van Kooten HA, van der Beek NAME et al. Chest MRI to diagnose early diaphragmatic weakness in Pompe disease. Orphanet Journal of Rare Diseases. 2021;16(1):1-12. 21. https://doi.org/10.1186/s13023-020-01627-x

Author

Harlaar, Laurike ; Ciet, Pierluigi ; van Tulder, Gijs ; Pittaro, Alice ; van Kooten, Harmke A. ; van der Beek, Nadine A.M.E. ; Brusse, Esther ; Wielopolski, Piotr A. ; de Bruijne, Marleen ; van der Ploeg, Ans T. ; Tiddens, Harm A.W.M. ; van Doorn, Pieter A. / Chest MRI to diagnose early diaphragmatic weakness in Pompe disease. In: Orphanet Journal of Rare Diseases. 2021 ; Vol. 16, No. 1. pp. 1-12.

Bibtex

@article{641093c5979447688be1890ae56932b6,
title = "Chest MRI to diagnose early diaphragmatic weakness in Pompe disease",
abstract = "Background: In Pompe disease, an inherited metabolic muscle disorder, severe diaphragmatic weakness often occurs. Enzyme replacement treatment is relatively ineffective for respiratory function, possibly because of irreversible damage to the diaphragm early in the disease course. Mildly impaired diaphragmatic function may not be recognized by spirometry, which is commonly used to study respiratory function. In this cross-sectional study, we aimed to identify early signs of diaphragmatic weakness in Pompe patients using chest MRI. Methods: Pompe patients covering the spectrum of disease severity, and sex and age matched healthy controls were prospectively included and studied using spirometry-controlled sagittal MR images of both mid-hemidiaphragms during forced inspiration. The motions of the diaphragm and thoracic wall were evaluated by measuring thoracic cranial-caudal and anterior–posterior distance ratios between inspiration and expiration. The diaphragm shape was evaluated by measuring the height of the diaphragm curvature. We used multiple linear regression analysis to compare different groups. Results: We included 22 Pompe patients with decreased spirometry results (forced vital capacity in supine position < 80% predicted); 13 Pompe patients with normal spirometry results (forced vital capacity in supine position ≥ 80% predicted) and 18 healthy controls. The mean cranial-caudal ratio was only 1.32 in patients with decreased spirometry results, 1.60 in patients with normal spirometry results and 1.72 in healthy controls (p < 0.001). Anterior–posterior ratios showed no significant differences. The mean height ratios of the diaphragm curvature were 1.41 in patients with decreased spirometry results, 1.08 in patients with normal spirometry results and 0.82 in healthy controls (p = 0.001), indicating an increased curvature of the diaphragm during inspiration in Pompe patients. Conclusions: Even in early-stage Pompe disease, when spirometry results are still within normal range, the motion of the diaphragm is already reduced and the shape is more curved during inspiration. MRI can be used to detect early signs of diaphragmatic weakness in patients with Pompe disease, which might help to select patients for early intervention to prevent possible irreversible damage to the diaphragm.",
keywords = "Diaphragm, Lysosomal storage disease, MRI, Neuromuscular disease, Pompe disease, Respiratory function",
author = "Laurike Harlaar and Pierluigi Ciet and {van Tulder}, Gijs and Alice Pittaro and {van Kooten}, {Harmke A.} and {van der Beek}, {Nadine A.M.E.} and Esther Brusse and Wielopolski, {Piotr A.} and {de Bruijne}, Marleen and {van der Ploeg}, {Ans T.} and Tiddens, {Harm A.W.M.} and {van Doorn}, {Pieter A.}",
year = "2021",
doi = "10.1186/s13023-020-01627-x",
language = "English",
volume = "16",
pages = "1--12",
journal = "Orphanet Journal of Rare Diseases",
issn = "1750-1172",
publisher = "BioMed Central",
number = "1",

}

RIS

TY - JOUR

T1 - Chest MRI to diagnose early diaphragmatic weakness in Pompe disease

AU - Harlaar, Laurike

AU - Ciet, Pierluigi

AU - van Tulder, Gijs

AU - Pittaro, Alice

AU - van Kooten, Harmke A.

AU - van der Beek, Nadine A.M.E.

AU - Brusse, Esther

AU - Wielopolski, Piotr A.

AU - de Bruijne, Marleen

AU - van der Ploeg, Ans T.

AU - Tiddens, Harm A.W.M.

AU - van Doorn, Pieter A.

PY - 2021

Y1 - 2021

N2 - Background: In Pompe disease, an inherited metabolic muscle disorder, severe diaphragmatic weakness often occurs. Enzyme replacement treatment is relatively ineffective for respiratory function, possibly because of irreversible damage to the diaphragm early in the disease course. Mildly impaired diaphragmatic function may not be recognized by spirometry, which is commonly used to study respiratory function. In this cross-sectional study, we aimed to identify early signs of diaphragmatic weakness in Pompe patients using chest MRI. Methods: Pompe patients covering the spectrum of disease severity, and sex and age matched healthy controls were prospectively included and studied using spirometry-controlled sagittal MR images of both mid-hemidiaphragms during forced inspiration. The motions of the diaphragm and thoracic wall were evaluated by measuring thoracic cranial-caudal and anterior–posterior distance ratios between inspiration and expiration. The diaphragm shape was evaluated by measuring the height of the diaphragm curvature. We used multiple linear regression analysis to compare different groups. Results: We included 22 Pompe patients with decreased spirometry results (forced vital capacity in supine position < 80% predicted); 13 Pompe patients with normal spirometry results (forced vital capacity in supine position ≥ 80% predicted) and 18 healthy controls. The mean cranial-caudal ratio was only 1.32 in patients with decreased spirometry results, 1.60 in patients with normal spirometry results and 1.72 in healthy controls (p < 0.001). Anterior–posterior ratios showed no significant differences. The mean height ratios of the diaphragm curvature were 1.41 in patients with decreased spirometry results, 1.08 in patients with normal spirometry results and 0.82 in healthy controls (p = 0.001), indicating an increased curvature of the diaphragm during inspiration in Pompe patients. Conclusions: Even in early-stage Pompe disease, when spirometry results are still within normal range, the motion of the diaphragm is already reduced and the shape is more curved during inspiration. MRI can be used to detect early signs of diaphragmatic weakness in patients with Pompe disease, which might help to select patients for early intervention to prevent possible irreversible damage to the diaphragm.

AB - Background: In Pompe disease, an inherited metabolic muscle disorder, severe diaphragmatic weakness often occurs. Enzyme replacement treatment is relatively ineffective for respiratory function, possibly because of irreversible damage to the diaphragm early in the disease course. Mildly impaired diaphragmatic function may not be recognized by spirometry, which is commonly used to study respiratory function. In this cross-sectional study, we aimed to identify early signs of diaphragmatic weakness in Pompe patients using chest MRI. Methods: Pompe patients covering the spectrum of disease severity, and sex and age matched healthy controls were prospectively included and studied using spirometry-controlled sagittal MR images of both mid-hemidiaphragms during forced inspiration. The motions of the diaphragm and thoracic wall were evaluated by measuring thoracic cranial-caudal and anterior–posterior distance ratios between inspiration and expiration. The diaphragm shape was evaluated by measuring the height of the diaphragm curvature. We used multiple linear regression analysis to compare different groups. Results: We included 22 Pompe patients with decreased spirometry results (forced vital capacity in supine position < 80% predicted); 13 Pompe patients with normal spirometry results (forced vital capacity in supine position ≥ 80% predicted) and 18 healthy controls. The mean cranial-caudal ratio was only 1.32 in patients with decreased spirometry results, 1.60 in patients with normal spirometry results and 1.72 in healthy controls (p < 0.001). Anterior–posterior ratios showed no significant differences. The mean height ratios of the diaphragm curvature were 1.41 in patients with decreased spirometry results, 1.08 in patients with normal spirometry results and 0.82 in healthy controls (p = 0.001), indicating an increased curvature of the diaphragm during inspiration in Pompe patients. Conclusions: Even in early-stage Pompe disease, when spirometry results are still within normal range, the motion of the diaphragm is already reduced and the shape is more curved during inspiration. MRI can be used to detect early signs of diaphragmatic weakness in patients with Pompe disease, which might help to select patients for early intervention to prevent possible irreversible damage to the diaphragm.

KW - Diaphragm

KW - Lysosomal storage disease

KW - MRI

KW - Neuromuscular disease

KW - Pompe disease

KW - Respiratory function

UR - http://www.scopus.com/inward/record.url?scp=85098871795&partnerID=8YFLogxK

U2 - 10.1186/s13023-020-01627-x

DO - 10.1186/s13023-020-01627-x

M3 - Journal article

C2 - 33413525

AN - SCOPUS:85098871795

VL - 16

SP - 1

EP - 12

JO - Orphanet Journal of Rare Diseases

JF - Orphanet Journal of Rare Diseases

SN - 1750-1172

IS - 1

M1 - 21

ER -

ID: 255060170